SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ANTEO DIAGNOSTICS LIMITED(ADO)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
ANTEOTECH LTD15/11/2019
ANTEO DIAGNOSTICS LIMITED25/11/200815/11/2019
BIOLAYER CORPORATION LIMITED23/01/200625/11/2008
S.S.H. MEDICAL LIMITED23/01/2006

Shareholder links

Our website ranking of ADO: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Unit 4, 26 Brandl Street, EIGHT MILE PLAINS, QLD, AUSTRALIA, 4113
Tel:  (07) 3219 0085 Fax: (07) 3219 0553

Date first listed: 07/04/2000
Company Secretary: Duncan Cornish
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Developing and commercialising medical products

News & Events

Expand this box to read and print

OFX Transferring Money Internationally to Free

name changed to AnteoTech Ltd

15/11/2019

The suspension of trading in the securities of Anteo Diagnostics Limited will be lifted prior to the commencement of trading on Monday, 9 October 2017 following lodgement of the Company's Annual Report for the full year ended 30 June 2017.

06/10/2017

The company lodges its Annual Report to shareholders 30 June 2017.

06/10/2017

The company releases its Corporate Governance Statement.

06/10/2017

The company releases an Appendix 4G.

06/10/2017

The securities of the company will be suspended from official quotation from the commencement of trading today, 2 October 2017, following failure to lodge its full year accounts for the period ended 30 June 2017 in accordance with ASX listing rules.

02/10/2017

The suspension of trading in the securities of Anteo Diagnostics Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding revised terms in relation to the acquisition of DIAsource ImmunoAssays S.A by the Company. Security Code: ADO

06/01/2016

Anteo Diagnostics Limited has agreed revised terms to acquire 100% of the equity in global specialty diagnostics company, DIAsource ImmunoAssays S.A. (Belgium), in line with previously announced acquisition. The originally announced Purchase Price of €15.4m (A$23.7m), with a two year earn out to vendors, subject to achievement of financial business targets (up to a maximum of €7.3m) remains the same. The Purchase Price consideration (€15.4m) is now to be paid 50% in cash up-front (€7.7m) and the balance (€7.7m) to be paid via a deferred payment plan.

06/01/2016

The securities of Anteo Diagnostics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the proposed revision of terms of the proposed DIAsource acquisition. Security Code: ADO

05/01/2016

name changed from Biolayer Corporation Limited

25/11/2008

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    20/11/2018Jack Hamilton1,000,000$0.015$15,000
    30/04/2018Jack Hamilton1,050,000$0.014$14,700
    09/11/2017John Hurrell500,000$0.018$9,000
    28/03/2014Geoffrey Cumming-4,000,000$0.258$1,031,599

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jack HamiltonNon Exec Chairman01/04/2018
    Derek ThomsonCEO26/08/2019
    Tamara MillsCOO15/08/2016
    Duncan CornishCFO28/02/2019
    Geoffrey CummingNon Exec Director02/04/2009
    Richard MartinDirector23/09/2005
    Matthew SandersonDirector19/10/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Christopher ParkerCEO23/04/201826/08/2019
    Harley FrankfurtCEO23/04/201922/07/2019
    Glenn McInallyCFO31/07/201728/02/2019
    Stefan EnderlingCEO01/01/201827/04/2018
    John HurrellExecutive Chairman01/09/201731/03/2018
    Rolf SickmanNon Exec Director29/01/201631/03/2018
    Alan StudleyNon Exec Director11/05/201716/11/2017
    Jef VangenechtenCEO14/06/201601/09/2017
    Peter Harding-SmithCFO04/10/201631/07/2017
    Mark BourisNon Exec Chairman05/08/201114/11/2016
    Sam AndersenNon Exec Director13/05/201125/08/2016
    James HendersonNon Exec Chairman13/05/2011
    Lara IacussoNon Exec Director25/02/2011
    Robert GilmourDirector03/11/2010
    Bruce RathieNon Exec Chairman03/07/200626/08/2009
    Peter RaynerNon Exec Director03/07/200616/09/2008
    David BeinsCEO01/04/200613/06/2008
    Carrie HillyardNon Exec Director23/09/200515/04/2008
    Tony EvansNon Exec Director03/07/200615/04/2008
    Stephen ErichsenNon Exec Director03/09/200421/11/2006
    Kim McGrathNon Exec Chairman30/04/200403/07/2006
    Jason ArmstrongExecutive Director23/09/200503/07/2006
    Henry StenningNon Exec Director05/04/200423/09/2005
    John MaherNon Exec Director28/10/200325/08/2004
    John DunnManaging Director05/07/2004
    Lorna StoneChairman30/06/2004
    Frank BurkeChairman10/07/200131/12/2003
    Clemens Der WeegenExecutive Director01/07/199528/11/2003
    Julie NuttingNon Exec Director20/08/2003
    Jennifer WilyNon Exec Director01/08/199920/06/2003
    Michael HoughtonNon Exec Director01/11/199819/08/2002

    Date of first appointment, title may have changed.